Frontier Capital Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Frontier Capital Management's PRCT Position: Q3 2026 in Review
Frontier Capital Management increased its Procept Biorobotics (PRCT) stake by 70% in Q3 2026, buying an estimated $15.2M and bringing the position to 1,853,183 shares worth $33.8M. The position accounts for 0.36% of the portfolio, ranked #105.
Frontier Capital Management first reported a position in PRCT in Q4 2024 and has held it in 8 quarters since. 225 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Frontier Capital Management held 1,853,183 shares of Procept Biorobotics worth $33.8M as of Q3 2026.
- Frontier Capital Management bought 761,655 Procept Biorobotics shares in Q3 2026, an estimated $15.2M.
- Procept Biorobotics made up 0.36% of Frontier Capital Management's portfolio in Q3 2026, its #105 holding.
- Frontier Capital Management first reported a position in Procept Biorobotics in Q4 2024 and has held it in 8 quarters since.
- 225 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Frontier Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.